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Background: Forced vital capacity (FVC) and maximal inspiratory pressure correlate with
nocturnal hypoventilation in adults with neuromuscular disease, but children may not be able
to perform these volitional tests.
Objective: To identify volitional and non-volitional parameters reflecting lung and respiratory
muscle function which differ in children treated or not with nocturnal noninvasive positive
pressure ventilation (NPPV).
Methods: Parameters reflecting lung function and respiratory muscle performance were
measured in 27 children not treated with NPPV (Unventilated group) and 8 children treated
with NPPV (Ventilated group).
Results: Concerning noninvasive tests, the Ventilated group had a rapid shallow breathing and
a lower ventilatory response to carbon dioxide compared to the Unventilated group. FVC (per-
formed by 69% of the patients) and sniff nasal inspiratory pressure were lower in the Ventilated
group. Concerning invasive tests, the non-volitional measurement of diaphragmatic strength
by magnetic stimulation of the phrenic nerves showed lower results in the Ventilated group
as compared to the Unventilated group. Volitional tests evaluating inspiratory and expiratory
muscle strength and endurance by means of the sniff and cough manoeuvres and the tension
time indexes, revealed lower values in the Ventilated group as compared to the Unventilated
group.
Conclusions: Several lung function and respiratory muscle function tests are lower in children
treated with NPPV as compared to children not treated with NPPV. A prospective hierarchicaltal Armand Trousseau, Pediatric Pulmonary Department, Research unit INSERM UMR S-893 Equipe 12,
, 28 avenue du Docteur Arnold Netter, Paris F-75012, France. Tel.: þ33 1 44 73 67 18; fax: þ33 1 44 73
rs.aphp.fr (B. Fauroux).
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Noninvasive ventilation and neuromuscular disease 575evaluation of these tests, according to their feasibility and invasiveness, may be helpful to
identify children with neuromuscular disease at risk for nocturnal hypoventilation.
ª 2008 Elsevier Ltd. All rights reserved.Introduction
Respiratory muscles are rarely spared in children with
neuromuscular disorders, even if the severity and course of
respiratory muscle weakness varies according to the
underlying disease.1 This progressive weakness of the
respiratory muscles exposes these patients to recurrent
chest infections, sleep-disordered breathing, and ulti-
mately respiratory failure.2,3 Noninvasive positive pressure
ventilation (NPPV) is recommended in case of episodes of
severe acute respiratory failure or nocturnal hyper-
capnia.4,5 Nocturnal NPPV reverses alveolar hypoventilation
and normalises daytime gas exchange.6
Detecting when a patient is at risk for acute respiratory
failure or nocturnal alveolar hypoventilation constitutes
a major challenge in children with neuromuscular disease.
Some lung function parameters, such as forced vital
capacity (FVC) have been shown to predict nocturnal
hypercapnia in patients with Duchenne muscular dystrophy
(DMD).7 In another study, inspiratory vital capacity and
peak inspiratory pressure were predictive of sleep-disor-
dered breathing in children with primary myopathies,8 but
only approximately 60% of young children with neuromus-
cular disease are able to realise these volitional manoeu-
vres.1 It would thus be useful to have non-volitional tests,
which may be realised by children unable to perform
reproducible inspiratory and expiratory manoeuvres, in
order to identify those at risk for alveolar hypoventilation
or respiratory failure.
Routine monitoring of lung function and respiratory
muscle strength, by means of the measure of FVC and
maximal inspiratory and expiratory pressures, is recom-
mended for patients with neuromuscular disease.9 We have
adapted these recommendations to the age of our neuro-
muscular patients by including non-volitional and invasive
respiratory muscle tests.1
The aim of the present study was thus to identify, in
a group of children with neuromuscular disease, volitional
and non-volitional parameters reflecting lung and respira-
tory muscle function, able to separate patients who were
treated or not with nocturnal NPPV.
Material and methods
Patients
The patients were recruited on a consecutive basis and were
included in the study if they 1) had a documented neuro-
muscular disease, 2) had been clinically stable for at least
one month; 3) did not receive any medication that could
influence ventilatory response. Some patients received
nocturnal NPPV, which was started when necessary
according to the international recommendations, i.e. in
case of nocturnal alveolar hypoventilation and/or a history
of respiratory failure requiring invasive ventilation.4,5 Thestudy was approved by the hospital ethics committee and
patients and parents gave their informed consent.
Lung function and respiratory muscle tests
Noninvasive non-volitional tests
The protocol started with the determination of breathing
pattern. The patient remained in the sitting position and
breathed room air for almost 2 min to achieve a steady
state for end tidal carbon dioxide (PETCO2). Breathing
pattern was determined from flow tracing, measured by
a pneumotachograph (Fleisch # 3, Lausanne, Switzerland)
which was attached to a mouthpiece. Tidal volume (VT) and
minute ventilation (VE) were expressed in ml/kg and the
ratio of breathing rate/VT (fR/VT) was calculated.
Thereafter, in order to determine the ventilatory
reserve of the patient, the ventilatory response to carbon
dioxide (CO2) was determined.
10 The patient was switched
to a 6 l bag of 5% CO2 in oxygen. After equilibrium was
observed between the rebreathing bag and the lungs,
rebreathing continued for 4 min. The slope of ventilatory
response to CO2 was obtained by performing least-square
linear regression between VE and PETCO2 obtained breath-
by-breath during the rebreathing period. Total respiratory
duration, VT, VE, and PETCO2 as the end tidal value were
determined. Records were analysed by plotting VT (VT/
slope), fR (fR/slope), and VE (VE/slope) against PETCO2.
After 15 min rest, functional residual capacity (FRC
helium) was measured by the helium dilution technique.
The resistance of the respiratory system (Rrsint) was
measured by the interruption method.11
Noninvasive volitional tests: forced vital capacity,
maximal pressures and sniff nasal inspiratory pressure
Thereafter, the patient was asked to perform at least 3
physician-accepted FVC curves and the curve with the
highest FVC was used for the analysis.
Maximal inspiratory (Pimax) and expiratory pressures
(Pemax) were measured from functional residual capacity
(FRC) and total lung capacity, respectively. Patients were
asked to perform 5 measurements or more until two
reproducible maximal values were obtained. The best value
was retained for analysis and the mean value that could be
maintained for one second was calculated.12
In order to determine the strength of the inspiratory
muscles, the patient was asked to perform at least 10e20
short, sharp maximal sniffs and the maximum sniff nasal
inspiratory pressure (SNIP) was noted.13
Invasive non-volitional tests: paradoxal breathing,
respiratory muscle output, magnetic stimulation of the
phrenic nerves, and dynamic lung compliance
After the noninvasive tests, an oesogastric catheter was
inserted pernasally after careful local anesthesia (lidocaine
2%, Astra Zeneca, Rueil-Malmaison, France).14 This 2.1 mm
external diameter catheter mounted pressure transducer
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gastric pressure (Pgas)) and 35 cm (for the oesophageal
pressure (Pes)) from the distal tip (Gaeltec, Dunvegan, Isle
of Skye, UK). This catheter was advanced gently until the
distal tip was in the stomach and the proximal pressure
transducer in the middle portion of the oesophagus.
Appropriate placement of the Pes transducer was assessed
with the usual method.15 Adequate placement of the Pgas
transducer was ascertained by gentle manual pressure on
the patient’s abdomen to observe fluctuations in Pgas, as
well as asking the patient to swallow and verifying that the
sharp increase in Pes caused by oesophageal contraction
was not observed on the Pgas tracing. Pdi was obtained by
subtracting on line the Pes signal from the Pgas signal.
During quiet breathing, paradoxal breathing was
assessed by calculating the ratio of the Pgas swing to the
Pdi swing (DPgas/DPdi), which is an index that reflects the
relative contribution of the diaphragm to tidal breathing.16
A negative DPgas/DPdi signifies paradoxical movement of
the diaphragm.
The patient’s inspiratory effort during quiet breathing
was assessed by measuring Pes, Pdi, and the oesophageal
(PTPes) and diaphragmatic pressureetime products
(PTPdi). The PTPes product by breath (PTPes/breath) was
obtained by measuring the area under Pes signal between
the onset of inspiratory effort and the end of inspiration,
and was referred to the chest wall static recoil pressuree
time relationship according to a methodology adapted from
Sassoon and colleagues.17 The PTPdi/breath was obtained
by measuring the area under the Pdi signal from the onset
of its positive deflection to the end of inspiratory flow. Both
PTPes and PTPdi were also expressed per minute by
multiplying the pressureetime products per breaths by the
breathing frequency (PTPes/min and PTPdi/min), values in
healthy adults being around 100 cm H2O s min
1.18
In order to assess the strength of the diaphragm, the
unpotentiated trandiaphragmatic pressure during a twitch
(TwPdi) elicited by phrenic nerve stimulation by the bilat-
eral anterior magnetic phrenic stimulation (BAMPS) tech-
nique was used as a non-volitional index of diaphragm
strength.1,19 The principle of this test is the creation of
a magnetic field which depolarises the neural structures,
i.e. the phrenic nerves in case of BAMPS, resulting in the
non-volitional contraction of the diaphragm. At least five
phrenic nerve stimulations were obtained in each patient
and the mean value was calculated.1,19
Finally, dynamic lung compliance (CLdyn) was measured
during quiet breathing as previously described.20
Invasive volitional tests: sniff and cough manoeuvre, and
respiratory muscle endurance
The strength of the inspiratory muscles was measured again
by asking the patient to perform the sniff manoeuvre but
this time, maximal Sniff Pes and Sniff Pdi were measured.
The strength of the expiratory muscles was measured by
asking the patient to perform a maximal cough. The peak
Pgas value of at least 5 maximal coughs was measured.21
The diaphragmatic tension time index (TTdi), which
estimates the endurance of the diaphragm, was calculated
during quiet breathing as TTdiZ (Pdi/Sniff Pdi) Ti/Ttot,
where PdiZmean Pdi during spontaneous breathing, Sniff
PdiZ Pdi during a maximal sniff, TiZ inspiratory time, andTtotZ total breath time. The oesophageal tension time
index (TTes), which estimates the overall endurance of the
inspiratory muscles, was calculated as TTesZ (Pes/Sniff
Pes) Ti/Ttot where PesZmean Pes during spontaneous
breathing and Sniff PesZ Pes during a maximal sniff.
Finally, arterial oxygen partial pressure (PaO2) and
PaCO2 were measured after a 30 min rest from arterialised
earlobe capillary blood gases.22Statistical analysis
Data are expressed as mean values SD. Comparisons
between the unventilated and ventilated patients were
performed with the one tailed Student t test. A p value
smaller than 0.05 indicated statistical significance.
Results
Description of the population
Thirty-five patients were included in the study, 20 patients
with Duchenne muscular dystrophy (DMD) and 15 patients
with other neuromuscular diseases (Table 1). Twenty-seven
patients were not ventilated (Unventilated group, age range
7e17 years) and 8 patients were treated with long term
NPPV (Ventilated group, age range 5e19 years) (Table 1).
The Unventilated group comprised 17 patients with DMD, 2
patients with spinal muscular atrophy, and 8 patients with
other myopathies (merosine deficiency (nZ 1), gamma-
sarcoglycanopathy (nZ 1), unknown myopathy (nZ 6)).
The Ventilated group comprised 3 patients with DMD, 2
patients with spinal muscular atrophy and 3 patients with
unknown myopathies. Indications (not exclusive) for NPPV
were as follows: diurnal hypercapnia in 3 patients, respira-
tory failure requiring invasive ventilation in 2 patients,
nocturnal hypercapnia with clinical symptoms of sleep-
disordered breathing in 5 patients, and a FVC less than 30%
in 3 patients. All the patients received exclusively nocturnal
NPPV. The mean duration on NPPV was 20 11 months
(range 3e36 months).
No significant differences were observed between the
DMD patients and the patients with other neuromuscular
diseases with regard to the breathing pattern, lung function
parameters, ventilatory response to CO2, respiratory
muscle strength, TT indices, PTPes, and PTPdi (data not
shown).
Comparison of the unventilated group and the
Ventilated group
Mean weight was significantly lower in Ventilated group as
compared to the Unventilated group but the other
anthropometric data were comparable between the two
groups (Table 1).
Concerning the noninvasive non-volitional tests, mean
VT, fR, and VE did not differ between the two groups but the
Ventilated group had a rapid shallow breathing with
a significantly higher fR/VT ratio than the Unventilated
group (Fig. 1). The mean VT and VE slope during CO2
rebreathing were significantly lower in the Ventilated
Table 1 Characteristics and comparison of the patients not ventilated (Unventilated group) and ventilated by nasal positive
pressure ventilation (Ventilated group).
Unventilated group nZ 27 Ventilated group nZ 8 p
Patient characteristics
Age (years) 12 3 12 5 NS
Body weight (kg) 43 17 29 9 0.03
Duchenne muscular dystrophy 17 3
Other neuromuscular diseases 10 5
PaO2 (mm Hg) 91 6 90 5 NS
PaCO2 (mm Hg) 38 2 38 2 NS
Noninvasive non-volitional tests
Respiratory parameters
VT (ml/kg) 8.6 3.0 8.3 2.8 NS
fR (breaths/min) 22 7 27 8 NS
VE (ml/kg/min) 189 94 220 85 NS
fR/VT (breaths/min/ml) 0.71 0.29 1.47 0.87 <0.0001
Ventilatory response to CO2
VT/slope 0.88 0.60 0.16 0.70 0.007
fR/slope 0.23 0.7 0.36 1.0 NS
VE/slope 22.5 10.7 8.9 8.1 0.002
Lung function parameters
FRC helium (% predicted) 90 23 78 30 NS
Rsint (% predicted) 200 57 159 68 NS
Noninvasive volitional tests
FVC (% predicted) 59 14 (nZ 20) 24 7 (nZ 4) 0.0001
Pemax (cm H2O) 32 14 (nZ 17) 18 11 (nZ 3) NA
Pimax (cm H2O) 42 25 (nZ 17) 34 7 (nZ 3) NA
SNIP (cm H2O) 47 15 17 9 <0.0001
Invasive non-volitional tests
DPgas/DPdi 0.03 0.2 0.13 0.5 NS
CLdyn (ml/cm H2O) 82 57 40 29 0.055
TwPdi 11.3 4.8 4.8 2.6 0.009
Respiratory muscle output
PTPes/min (cm H2O$ s$min
1) 146 51 168 56 NS
PTPdi/min (cm H2O$ s$min
1) 227 90 300 204 NS
Invasive volitional tests
Respiratory muscle performance
Sniff Pes (cm H2O) 55 15 23 8 <0.001
Sniff Pdi (cm H2O) 57 19 31 18 0.002
Pgas cough (cm H2O) 52 18 25 12 0.001
Respiratory muscle endurance
TTdi 0.07 0.03 0.16 0.06 <0.0001
TTes 0.05 0.02 0.13 0.06 <0.0001
Data are presented as mean SD.
Abbreviations: VT, tidal volume; fR, respiratory rate; fR/VT, respiratory rate/tidal volume ratio; VE, minute ventilation; CO2, carbon
dioxide; FRC helium, functional residual capacity measured by the helium dilution technique; Rsint, resistance of the respiratory system
measured by the interruption technique; FVC, forced vital capacity; SNIP, sniff nasal inspiratory pressure; DPgas/DPdi, ratio of gastric
pressure swing to transdiaphragmatic pressure swing during spontaneous breathing; CLdyn, dynamic lung compliance; TwPdi, trans-
diaphragmatic pressure obtained by the magnetic stimulation of the phrenic nerves; PTPes, esophageal pressure time product; PTPdi,
diaphragmatic pressure time product; TTdi, tension time index of the diaphragm; TTes, tension time index of the inspiratory muscles;
Pes, esophageal pressure; Pdi, transdiaphragmatic pressure; Pgas cough, gastric pressure during a maximal cough manoeuvre; NS, not
significant; NA, not applicable because of the low number of patients (nZ 3) in the Ventilated group.































578 B. Fauroux et al.group as compared to the Unventilated group (Fig. 1) but
no difference was observed for FRC helium and Rsint.
With regard to the noninvasive volitional tests, mean
FVC and SNIP were significantly lower in the Ventilated
group as compared to the Unventilated group (Fig. 2). Mean
Pimax and Pemax were also lower in the Ventilated group
as compared to the Unventilated group but only 57% of the
patients were able to perform these tests, which did not
allow a statistical comparison between the two groups.
For the invasive non-volitional tests, only diaphragmatic
strength assessed by TwPdi was lower in the Ventilated
group as compared to the Unventilated group (Fig. 3).
Finally, with regard to the invasive volitional tests
evaluating inspiratory and expiratory muscle strength by
means of the sniff and cough manoeuvres, all these tests
revealed lower values in the Ventilated group as compared
to the Unventilated group (Fig. 4). The TT indexes were
also significantly higher in the Ventilated group as
compared to the Unventilated group, reflecting a lower







































































Figure 1 Comparison of the respiratory rate/tidal volume
ratio (fR/VT, top) and the ventilatory slope during carbon
dioxide rebreathing (Slope VE, bottom) in the patients not
treated with noninvasive positive pressure ventilation
(Unventilated group) and the patients treated with noninva-
sive positive pressure ventilation (Ventilated group).























Figure 2 Comparison of the forced vital capacity (FVC, top)
and the sniff nasal inspiratory pressure (SNIP, bottom) in the
patients not treated with noninvasive positive pressure venti-
lation (Unventilated group) and the patients treated with
noninvasive positive pressure ventilation (Ventilated group).
): pZ 0.0001, )): p< 0.0001.Discussion
This study shows that a number of parameters assessing
breathing pattern, lung function, and respiratory muscle
strength and endurance differed between children
receiving or not NPPV. FVC has been shown to be associated
with the need of NPPV, but young children are not always
able to adequately realise this volitional test. Other
noninvasive parameters, such as fR/VT ratio, VE slope during
CO2 rebreathing, and SNIP are thus worth to be evaluated as
predictive markers of alveolar hypoventilation or respira-
tory failure in children with neuromuscular disease. Several
invasive tests differed also between patients receiving or
not NPPV, but their invasiveness limits their use in clinical
practice.
Noninvasive non-volitional tests
The fR/VT ratio, a measure of rapid shallow breathing
introduced by Yang and Tobin,23 has been validated as
a useful index for predicting ventilatory failure and

























Figure 3 Comparison of the transdiaphragmatic pressure
measured during magnetic stimulation of the phrenic nerves
(TwPdi) in the patients not treated with noninvasive positive
pressure ventilation (Unventilated group) and the patients
treated with noninvasive positive pressure ventilation (Venti-
lated group). ): p< 0.009.
Noninvasive ventilation and neuromuscular disease 579neuromuscular disease tend to have a higher fR/VT ratio
than healthy controls25 and in patients with DMD, the fR/VT
ratio may distinguish patients with nocturnal hypercapnia
from those with 24-h normocapnia.7 These observations are
in agreement with the results of our pediatric population
which showed a significant higher fR/VT ratio in the Venti-










































Figure 4 Comparison of the oesophageal pressure during a snif
a maximal cough (Pgas cough, bottom right), and the oesophageal
with noninvasive positive pressure ventilation (Unventilated group
ventilation (Ventilated group). ): p< 0.001, )): pZ 0.001, ))):The ventilatory response to CO2 reflects the capacity of
the respiratory system to respond to a strong chemical
stimulus. We have shown that the ventilatory response to
CO2 is reduced in young patients with cystic fibrosis because
of an increase in respiratory load.10 In the present study,
the VT/slope and VE/slope were significantly lower in the
Ventilated group as compared to the Unventilated group,
reflecting a greater level of respiratory muscle weakness in
the Ventilated group.
Noninvasive volitional tests
FVC is a global marker of the strength of the inspiratory and
expiratory muscles. FVC has been shown to be a strong
predictor of nocturnal hypercapnia in patients with DMD,
and as such, is recommended as a first line and routine test
for the follow up of patients with neuromuscular
disease.9,26 But approximately 40% of young children with
neuromuscular disease are unable to perform a reliable,
reproducible FVC manoeuvre.1 Another variant has thus
been evaluated in children; the inspiratory vital capacity
(IVC), which has been associated with sleep-disordered
breathing in patients with primary myopathies.2 But still,
other tests, easier to perform in young children, would be
useful.
The SNIP is an accurate, simple, and easy to perform
test even by young children to estimate the strength of
the inspiratory muscles.1 This test has been shown to have
the highest predictive value of daytime hypercapnia in
patients with amyotrophic lateral sclerosis, greater than

































f manoeuvre (Sniff Pes, top left), the gastric pressure during
tension time index (TTes, bottom) in the patients not treated
) and the patients treated with noninvasive positive pressure
p< 0.001.
580 B. Fauroux et al.present study, the SNIP values were significantly lower in
the Ventilated group as compared to the Unventilated
group. Because of its simplicity, this test may be recom-
mended as a first line test in children with neuromuscular
disease and should be given priority for future prospective
studies.
Invasive non-volitional tests
Even if sniff manoeuvres are more accurate and reproduc-
ible than isometric manoeuvres such as maximal pressures,
these tests still require the understanding and the co-
operation of the patient. Stimulation of the phrenic nerves
is the only respiratory muscle test that requires no co-
operation of the patient. In our experience, TwPdi is well
accepted and tolerated in children and is useful to assess
diaphragmatic strength in patients with cystic fibrosis19 and
neuromuscular disease.1 In the present study, this test
confirmed the significantly greater weakness of the dia-
phragm in the Ventilated group as compared to the
Unventilated group, but in clinical practice, its use is
limited by the fact that this test is available only in very
few centers.
CLdyn, reflecting lung compliance, was lower in the
Ventilated group but this difference did not reach statis-
tical significance. As observed previously in children with
neuromuscular disease, indices of respiratory effort, i.e.
PTPes and PTPdi, were comparable in the two groups.1 This
may signify that an increase in respiratory effort, conse-
quent to diffuse microatelectasis and decreased chest wall
compliance, probably due to stiffening of rib cage liga-
ments and ankylosis of the costovertebral and thor-
acovertebral joints, occurs early in children with
neuromuscular disease and precedes the need of NPPV.
Invasive volitional tests
Pgas cough was also lower in the Ventilated group as
compared to the Unventilated group. Pgas cough measures
the abdominal pressure that the patient can generate
during a cough manoeuvre. This pressure depends both on
the patient’s inspiratory capacity, thus the strength of the
inspiratory muscles, the mechanical properties of the rib
cage, and the force of the expiratory muscles. Cough is
a natural manoeuvre that even very young children are able
to perform. The measurement of cough peak flow by means
of a peak flow meter is a simple and noninvasive test that is
easily available in every pediatric clinic. However, coughing
through a peak flow meter, or even a face mask, may be
difficult for some children.
The TTconcept, originating in earlier studies of heart and
limb muscles, has been applied to the diaphragm by Belle-
mare and Grassino to determine its endurance characteris-
tics.28 The TT indices are dimensionless indices relating the
force developed by the respiratory muscles to the time that
they are being used. A value being associated with respira-
tory muscle fatigue has been determined for healthy
humans.28 Higher values of TT indices, reflecting lower
endurance levels, have beenmeasured in adults and children
with neuromuscular disease compared to healthy controls.29
The TT indices were significantly higher in the Ventilatedgroup than in the Unventilated group because of lower Sniff
Pes and Sniff Pdi values. The endurance of the respiratory
muscles in children with neuromuscular disease treated
with nocturnal NPPV was thus significantly lower than non-
ventilated patients.Limitations of the study
A limitation of this pilot study is that we compared an
Unventilated group with a Ventilated group. No longitu-
dinal follow up, with in particular an evaluation at the
start of NPPV, is available for this group of patients.
Indeed, some parameters may improve after NPPV. It has
been shown that long term nocturnal NPPV translates into
an improvement in alveolar ventilation which results in
a decrease in fR/VT30 and an improvement in nocturnal
and diurnal blood gases.30e33 This may explain why the
blood gases were not different between the two groups.
Also, NPPV has been shown to be associated with an
increase in the ventilatory response to CO2.
30 Impor-
tantly, FVC and respiratory muscle tests such as maximal
pressures do not change after NPPV.30,31,34,35 This rein-
forces the value of a prospective evaluation of SNIP as
a marker for respiratory failure or alveolar hypo-
ventilation in children with neuromuscular disease. Such
a prospective study should also include sleep data, which
are most important for the decision of NPPV.
With regard to the effect of NPPV on the respiratory
parameters, all the ventilated patients included in the
present study used their NPPV at least 6 h per night, as
checked regularly by the home care organisation. Their
routine sleep studies in the hospital showed also normal
nocturnal gas exchange with NPPV.
The heterogeneity of the diagnosis, the limited number
of patients in the Ventilated group, and the large age
distribution of the patients, represent other limitations of
the study. Indeed, predictors (and the thresholds) may vary
among the different neuromuscular diseases.36 Future
prospective studies should thus be able to include a suffi-
cient number of patients.
Practical implications
Several lung function and respiratory muscle function tests
are lower in children treated with NPPV as compared to
children not treated with NPPV. A prospective study is
actually underway to determine which tests would be the
most discriminate to identify children at risk for nocturnal
alveolar hypoventilation and sleep-disordered breathing.
Within this context, it is obvious that noninvasive, simple
tests, that may be performed by the largest number of
children, such as SNIP, will be given priority.
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